FindTrial
Sign In

Sthiradi Churna In Oligoasthenozoospermia

Efficacy Of Sthiradi Churna In The Management Of Oligoathenozoospermia-A Randomised Controlled Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/06/019806
Enrollment
20
Registered
2019-06-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N469- Male infertility, unspecified

Interventions

Intervention1: Sthiradi Churna in Oligoasthenozoospermia: Group A 10 Patients Sthiradi Churna 6 gms oral administration twice a daily with 125 ml milk for 60 days Group B 10 patients Churna ratnam 2gm

Sponsors

Dr Saish Gawas
Lead Sponsor
KAHERs SHRI B M KANKANWADI AYURVEDA MAHAVIDYALAYA POST GRADUATE STUDIES AND RESEARCH CENTRE
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed cases of Oligoasthenozoospermia. Subjects with age group of 20 to 45 years. Subject either married or unmarried.

Exclusion criteria

Exclusion criteria: Patient with uncontrolled metabolic diseases and any long-standing infections or any psychiatric illness. Patient undergone surgery for e.g. Vasectomy, etc. Patient with Varicocele, recent history of Mumps, Orchitis, Trauma, and Acute febrile illness.

Design outcomes

Primary

MeasureTime frame
Sthiradi Churna if proved efficacious would help in treating Oligoasthenozoospermia.Timepoint: After 60 days of intervention—

Secondary

MeasureTime frame
not applicableTimepoint: not applicable—

Countries

India

Contacts

Public ContactDr SUKUMAR NANDIGOUDAR

KAHERs SHRI B M KANKANWADI AYURVEDA MAHAVIDYALAYA POST GRADUATE STUDIES AND RESEARCH CENTRE

saishgawas21@gmail.com9049441955

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026